Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment

• Główni autorzy: Luis Sarabia De Ardanaz (Autor), Jose M. Andreu-Ubero (Autor), Miriam Navidad-Fuentes (Autor), Miguel Ángel Ferrer-González (Autor), Victor Ruíz del Valle (Autor), Inmaculada Salcedo-Bellido (Autor), Rocío Barrios-Rodríguez (Autor), Rafael Cáliz-Cáliz (Autor), Pilar Requena (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Tocilizumab (TCZ) has been administered in SARS-CoV-2 pneumonia but the factors associated with mortality before and after treatment remain unclear. Cox regression models were used to estimate the predictors of time to death in a cohort of hospitalized patients with COVID-19 receiving TCZ. In additi...